GlaxoSmithKline (Jobs) Distorted Seroxat Drug Test Data

LONDON, Jan 29 (Reuters) - GlaxoSmithKline Plc (GSK.L: Quote, Profile , Research) was accused on Monday of distorting clinical trial results of its antidepressant Seroxat, or Paxil, and covering up a link with suicide in teenagers.

>>> Discuss This Story

MORE ON THIS TOPIC